Stockscreener 앱 받기
2.44
3.17%
0.075
시장 영업 전:
2.45
0.01
+0.41%
Editas Medicine Inc 주식(EDIT)의 최신 뉴스
What valuation ratios show for Editas Medicine Inc. (8EM) stockEarnings Summary Report & Reliable Intraday Trade Alerts - Newser
How Editas Medicine Inc. (8EM) stock performs in easing cyclesJuly 2025 Selloffs & Safe Entry Momentum Tips - Newser
Editas Medicine (NASDAQ:EDIT) Shares Cross Below 50-Day Moving AverageTime to Sell? - MarketBeat
Will Editas Medicine Inc. (8EM) stock beat Nasdaq index returns2025 Pullback Review & Free Verified High Yield Trade Plans - Newser
Is Editas Medicine Inc. (8EM) stock positioned for digital growth eraMarket Growth Summary & Free Fast Gain Swing Trade Alerts - Newser
Euro India Fresh Foods Limited Forms Bullish Flag Upside AheadCovered Call Writing & Learn From the Strategies of Institutions - earlytimes.in
FY2025 EPS Estimates for Editas Medicine Lowered by Analyst - MarketBeat
Editas Medicine (NASDAQ:EDIT) Stock Crosses Below 50-Day Moving AverageTime to Sell? - MarketBeat
Portfolio Shifts: Is Editas Medicine Inc. stock a bargain at current levelsMarket Activity Recap & Fast Moving Stock Trade Plans - BỘ NỘI VỤ
Can Editas Medicine Inc. stock surprise with earnings upsideTrade Signal Summary & Fast Gain Stock Tips - moha.gov.vn
Editas Medicine Inc Stock Analysis and ForecastGeopolitical Risk Analysis & Access Free Risk Analysis Before You Invest - earlytimes.in
Editas Medicine price target raised to $4.60 from $4 at Clear Street - MSN
Is Editas Medicine Inc. (8EM) stock overpriced at current multiplesPortfolio Risk Report & Risk Controlled Swing Trade Alerts - newser.com
Is Editas Medicine Inc. (8EM) stock in buy zone after pullbackJuly 2025 Rallies & AI Powered Market Entry Strategies - newser.com
Will Editas Medicine Inc. (8EM) stock gain from green policies2025 Big Picture & Technical Confirmation Alerts - newser.com
Will Editas Medicine Inc. stock continue upward momentumForecast Cut & Free Technical Pattern Based Buy Signals - newser.com
How Editas Medicine Inc. (8EM) stock responds to job market shiftsJuly 2025 Snapshot & AI Enhanced Market Trend Forecasts - newser.com
Can Editas Medicine Inc. stock sustain market leadershipQuarterly Risk Review & Weekly Chart Analysis and Trade Guides - newser.com
Is Editas Medicine Inc. (8EM) stock expanding market penetrationFed Meeting & High Accuracy Swing Entry Alerts - newser.com
Does Editas Medicine Inc. (8EM) stock trade below intrinsic valueQuarterly Performance Summary & Verified Chart Pattern Trade Signals - newser.com
Why Is Editas (EDIT) Down 16.9% Since Last Earnings Report? - MSN
Is Editas Medicine Inc. stock a smart buy before Fed meetingWeekly Trading Summary & Stock Portfolio Risk Management - newser.com
Should you hold or exit Editas Medicine Inc. nowPortfolio Risk Summary & Verified Short-Term Trading Plans - newser.com
Brokers Set Expectations for Editas Medicine FY2026 Earnings - MarketBeat
Clear Street Lifts Price Target on Editas (EDIT) Medicine Amid Pipeline Progress - Insider Monkey
Gene Therapies for Cancer Treatment Market Projects USD 238.77 Billion at 39.94% CAGR by 2034 - GlobeNewswire Inc.
9 Best Gene-Editing Stocks to Buy According to Hedge Funds - Insider Monkey
Should I hold or sell Editas Medicine Inc. stock in 2025Rate Cut & Low Risk Growth Stock Ideas - newser.com
Editas Medicine (NASDAQ:EDIT) Upgraded by Chardan Capital to "Strong-Buy" Rating - MarketBeat
1.10%
1.10%
자본화:
|
볼륨(24시간):